ITRM
Iterum Therapeutics plc
NASDAQ · Healthcare · Biotechnology · IE
$0.03
−10.98%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-94.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Nov 20, 2025 | Dunne Michael W. · director | Purchase | 6,000 | $0.37 |
| Aug 12, 2025 | Dunne Michael W. · director | Purchase | 15,000 | $0.72 |
| Jul 3, 2025 | Coyne Christine · officer: Chief Commercial Officer | A-Award | 200,000 | $0.97 |
| Aug 12, 2024 | Dunne Michael W. · director | M-Exempt | 106,247 | $1.21 |
| Aug 12, 2024 | Dunne Michael W. · director | M-Exempt | 212,494 | $0.61 |
| Aug 12, 2024 | Fishman Corey N. · director, officer: Chief Executive Officer | M-Exempt | 82,613 | $1.21 |
| Aug 12, 2024 | Fishman Corey N. · director, officer: Chief Executive Officer | M-Exempt | 165,226 | $0.61 |
| Aug 12, 2024 | HUNT RONALD · director | M-Exempt | 182,453 | $1.21 |
| Aug 12, 2024 | HUNT RONALD · director | M-Exempt | 65,481 | $1.21 |
| Aug 12, 2024 | HUNT RONALD · director | M-Exempt | 130,962 | $0.61 |
| Dec 27, 2023 | Dunne Michael W. · director | Purchase | 25,000 | $1.40 |
| Dec 19, 2023 | Dunne Michael W. · director | Purchase | 10,000 | $1.84 |
| Dec 4, 2023 | Puttagunta Sailaja · officer: Chief Medical Officer | M-Exempt | 8,333 | $0.00 |
| Dec 4, 2023 | Puttagunta Sailaja · officer: Chief Medical Officer | A-Award | 8,333 | $0.00 |
| Dec 4, 2023 | Puttagunta Sailaja · officer: Chief Medical Officer | F-InKind | 2,933 | $2.12 |
| Nov 27, 2023 | Dunne Michael W. · director | Purchase | 20,000 | $2.03 |
| Nov 20, 2023 | Fishman Corey N. · director, officer: Chief Executive Officer | Purchase | 10,000 | $1.59 |
| Oct 2, 2023 | HUNT RONALD · director | M-Exempt | 5,479 | $0.00 |
| Oct 2, 2023 | Dunne Michael W. · director | M-Exempt | 3,487 | $0.00 |
| Jul 3, 2023 | Dunne Michael W. · director | M-Exempt | 1,779 | $0.00 |
| Jul 3, 2023 | HUNT RONALD · director | M-Exempt | 2,796 | $0.00 |
| Jun 15, 2023 | Hecht Beth · director | M-Exempt | 15,853 | $0.00 |
| Jun 15, 2023 | Dunne Michael W. · director | M-Exempt | 15,853 | $0.00 |
| Jun 15, 2023 | Chin Mark · director | M-Exempt | 15,853 | $0.00 |
| Jun 5, 2023 | Dunne Michael W. · director | M-Exempt | 1,299 | $0.00 |
| Apr 3, 2023 | HUNT RONALD · director | M-Exempt | 2,041 | $0.00 |
| Apr 3, 2023 | Matthews Judith M. · officer: Chief Financial Officer | A-Award | 100,000 | $1.00 |
| Apr 3, 2023 | Puttagunta Sailaja · officer: Chief Medical Officer | A-Award | 75,000 | $1.00 |
| Apr 3, 2023 | Dunne Michael W. · director | M-Exempt | 1,299 | $0.00 |
| Apr 3, 2023 | Fishman Corey N. · director, officer: Chief Executive Officer | A-Award | 275,000 | $1.00 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Nov 20, 2025